BriaCell Therapeutics Corp (BCTX)
0.6079
+0.01
(+1.38%)
USD |
NASDAQ |
Nov 14, 12:13
BriaCell Therapeutics Shareholders Equity (Quarterly): -2.382M for July 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | -2.382M |
April 30, 2024 | -5.965M |
January 31, 2024 | -8.073M |
October 31, 2023 | 2.721M |
July 31, 2023 | -3.777M |
April 30, 2023 | -5.892M |
January 31, 2023 | -1.281M |
October 31, 2022 | 10.33M |
July 31, 2022 | 10.33M |
April 30, 2022 | 45.82M |
January 31, 2022 | 47.70M |
October 31, 2021 | 55.39M |
July 31, 2021 | 27.67M |
April 30, 2021 | 13.82M |
January 31, 2021 | -3.631M |
October 31, 2020 | -3.369M |
July 31, 2020 | -3.597M |
April 30, 2020 | -2.756M |
January 31, 2020 | -2.262M |
October 31, 2019 | -0.8163M |
July 31, 2019 | -0.6887M |
April 30, 2019 | 0.6435M |
January 31, 2019 | -0.6046M |
October 31, 2018 | 0.3617M |
July 31, 2018 | 0.945M |
Date | Value |
---|---|
April 30, 2018 | 2.349M |
January 31, 2018 | 0.4698M |
October 31, 2017 | 0.9874M |
July 31, 2017 | 0.7502M |
April 30, 2017 | 1.577M |
January 31, 2017 | 1.362M |
October 31, 2016 | 1.614M |
July 31, 2016 | 0.7871M |
April 30, 2016 | 1.136M |
January 31, 2016 | 0.5221M |
October 31, 2015 | 0.8733M |
July 31, 2015 | 1.159M |
April 30, 2015 | 1.546M |
January 31, 2015 | 1.650M |
October 31, 2014 | 0.6096M |
July 31, 2014 | -0.0011M |
April 30, 2014 | 8.082M |
January 31, 2014 | 8.472M |
October 31, 2013 | 9.101M |
July 31, 2013 | 9.334M |
April 30, 2013 | 9.620M |
January 31, 2013 | 9.836M |
October 31, 2012 | 9.956M |
July 31, 2012 | 10.03M |
April 30, 2012 | 10.75M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.073M
Minimum
Jan 2024
55.39M
Maximum
Oct 2021
8.989M
Average
-2.262M
Median
Jan 2020
Shareholders Equity (Quarterly) Benchmarks
CeCors Inc | -- |
Venus Concept Inc | 3.702M |
Aurinia Pharmaceuticals Inc | 388.00M |
Edesa Biotech Inc | 2.867M |
Lexaria Bioscience Corp | 10.12M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.872M |
Total Liabilities (Quarterly) | 8.557M |